Cargando…
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
BACKGROUND: Systemic antibiotics vary widely in in vitro activity against Clostridium difficile. Some agents with activity against C. difficile (e.g., piperacillin/tazobactam) inhibit establishment of colonization in mice. We tested the hypothesis that piperacillin/tazobactam and other agents with a...
Autores principales: | Kundrapu, Sirisha, Sunkesula, Venkata C. K., Jury, Lucy A., Cadnum, Jennifer L., Nerandzic, Michelle M., Musuuza, Jackson S., Sethi, Ajay K., Donskey, Curtis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835867/ https://www.ncbi.nlm.nih.gov/pubmed/27091232 http://dx.doi.org/10.1186/s12879-016-1514-2 |
Ejemplares similares
-
Defining the Vulnerable Period for Re-Establishment of Clostridium difficile Colonization after Treatment of C. difficile Infection with Oral Vancomycin or Metronidazole
por: Abujamel, Turki, et al.
Publicado: (2013) -
1645 Do asymptomatic carriers of toxigenic Clostridium difficile identified through inappropriate testing represent a significant risk for transmission?
por: Kundrapu, Sirisha, et al.
Publicado: (2014) -
Outpatient Healthcare Settings and Transmission of Clostridium difficile
por: Jury, Lucy A., et al.
Publicado: (2013) -
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam
por: Garneau, Julian R, et al.
Publicado: (2014) -
Piperacillin/tazobactam/vancomycin: Clostridium difficile colitis: case report
Publicado: (2021)